Rafael Lopez-Lopez
Overview
Explore the profile of Rafael Lopez-Lopez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
1892
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mondelo-Macia P, Garcia-Gonzalez J, Leon-Mateos L, Abalo A, Bravo S, Chantada Vazquez M, et al.
Mol Cell Proteomics
. 2024 Aug;
23(10):100834.
PMID: 39216661
Immunotherapy has improved survival rates in patients with cancer, but identifying those who will respond to treatment remains a challenge. Advances in proteomic technologies have enabled the identification and quantification...
2.
Rapado-Gonzalez O, Salta S, Lopez-Lopez R, Henrique R, Suarez-Cunqueiro M, Jeronimo C
Clin Epigenetics
. 2024 Aug;
16(1):105.
PMID: 39138540
More than 50% of oral cancer (OC) patients are diagnosed with advanced-stage disease associated with poor prognosis and quality of life, supporting an urgent need to improve early OC detection....
3.
Rodriguez-Fuentes M, Perez-Sayans M, Barbeito-Castineiras G, Molares-Vila A, Prado-Pena I, Camolesi G, et al.
J Stomatol Oral Maxillofac Surg
. 2024 Jul;
125(5S2):101991.
PMID: 39084558
Objectives: Acute oral mucosal damage, as well as other inflammatory processes seem to be related to dysbiosis of the oral microbiome. The need to study changes in the oral microbiome...
4.
Rodriguez-Ces A, Rapado-Gonzalez O, Salgado-Barreira A, Santos M, Aroso C, Vinhas A, et al.
Diagnostics (Basel)
. 2024 Jul;
14(14).
PMID: 39061602
Liquid biopsies have been identified as a viable source of cancer biomarkers. We aim to evaluate the diagnostic accuracy of cell-free DNA integrity (cfDI) in liquid biopsies for cancer. A...
5.
Rosas-Alonso R, Colmenarejo-Fernandez J, Pernia O, Burdiel M, Rodriguez-Antolin C, Losantos-Garcia I, et al.
Sci Rep
. 2024 May;
14(1):11398.
PMID: 38762534
Glioblastoma (GB) is a devastating tumor of the central nervous system characterized by a poor prognosis. One of the best-established predictive biomarker in IDH-wildtype GB is O6-methylguanine-DNA methyltransferase (MGMT) methylation...
6.
Pereira-Veiga T, Bravo S, Gomez-Tato A, Yanez-Gomez C, Abuin C, Varela V, et al.
Mol Cell Proteomics
. 2024 May;
23(5):100774.
PMID: 38735273
No abstract available.
7.
Betancor Y, Ferreiro-Pantin M, Anido-Herranz U, Fuentes-Losada M, Leon-Mateos L, Garcia-Acuna S, et al.
Front Immunol
. 2024 Apr;
15:1374728.
PMID: 38660294
In the advanced renal cell carcinoma (RCC) scenario, there are no consistent biomarkers to predict the clinical benefit patients derived from immune checkpoint blockade (ICB). Taking this into consideration, herein,...
8.
Sequeira J, Salta S, Freitas R, Lopez-Lopez R, Diaz-Lagares A, Henrique R, et al.
Cancers (Basel)
. 2024 Apr;
16(7).
PMID: 38611041
Background: Prostate cancer (PCa) is one of the most frequently occurring malignancies. Although most cases are not life-threatening, approximately 20% endure an unfavorable outcome. PSA-based screening reduced mortality but at...
9.
Cinza-Sanjurjo S, Mazon-Ramos P, Rey-Aldana D, Garcia-Vega D, Portela-Romero M, Rodriguez-Manero M, et al.
Eur J Clin Invest
. 2024 Mar;
54(8):e14197.
PMID: 38519859
Background: The prevalence of cancer patients with concomitant cardiovascular (CV) disease is on the rise due to improved cancer prognoses. The aim of this study is to evaluate the long-term...
10.
Brozos-Vazquez E, Toledano-Fonseca M, Costa-Fraga N, Garcia-Ortiz M, Diaz-Lagares A, Rodriguez-Ariza A, et al.
Cancer Treat Rev
. 2024 Mar;
125:102719.
PMID: 38490088
Pancreatic cancer is one of the tumors with the worst prognosis, and unlike other cancers, few advances have been made in recent years. The only curative option is surgery, but...